{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:01:27Z","timestamp":1792022487367,"version":"4.4.0"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T00:00:00Z","timestamp":1458518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/cmi.2016.4","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T09:44:26Z","timestamp":1458553466000},"page":"354-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Adaptive immunity in the liver"],"prefix":"10.1038","volume":"13","author":[{"given":"Zongwen","family":"Shuai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda WY","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weici","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick SC","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Eric Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,21]]},"reference":[{"key":"BFcmi20164_CR1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/cphy.c120011","volume":"3","author":"DP Bogdanos","year":"2013","unstructured":"Bogdanos DP, Gao B, Gershwin ME . Liver immunology. Compr Physiol 2013; 3: 567\u2013598.","journal-title":"Compr Physiol"},{"key":"BFcmi20164_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jaut.2015.08.020","volume":"66","author":"DG Doherty","year":"2015","unstructured":"Doherty DG . Immunity, tolerance and autoimmunity in the liver: a comprehensive review. J Autoimmun 2015; 66: 60\u201375.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.08.011","volume":"66","author":"K Hudspeth","year":"2015","unstructured":"Hudspeth K, Donadon M, Cimino M, Pontarini E, Tentorio P, Preti M et al. Human liver-resident CD56\/CD16 NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J Autoimmun 2015; 66: 40\u201350.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaut.2014.10.006","volume":"56","author":"X Xu","year":"2015","unstructured":"Xu X, Zhang S, Jin R, Wang K, Li P, Lin L et al. Retention and tolerance of autoreactive CD4(+) recent thymic emigrants in the liver. J Autoimmun 2015; 56: 87\u201397.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2014.02.010","volume":"53","author":"H Zhang","year":"2014","unstructured":"Zhang H, Liu Y, Bian Z, Huang S, Han X, You Z et al. The critical role of myeloid-derived suppressor cells and FXR activation in immune-mediated liver injury. J Autoimmun 2014; 53: 55\u201366.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00281-009-0175-2","volume":"31","author":"C Selmi","year":"2009","unstructured":"Selmi C, Podda M, Gershwin ME . Old and rising stars in the lymphoid liver. Semin Immunopathol 2009; 31: 279\u2013282.","journal-title":"Semin Immunopathol"},{"key":"BFcmi20164_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","volume":"1","author":"LG Guidotti","year":"2006","unstructured":"Guidotti LG, Chisari FV . Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 2006; 1: 23\u201361.","journal-title":"Annu Rev Pathol"},{"key":"BFcmi20164_CR8","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev.immunol.20.100101.151926","volume":"20","author":"J Sprent","year":"2002","unstructured":"Sprent J, Surh CD . T cell memory. Annu Rev Immunol 2002; 20: 551\u2013579.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi20164_CR9","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.4049\/jimmunol.166.9.5430","volume":"166","author":"P Bertolino","year":"2001","unstructured":"Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B . Antigen-specific primary activation of CD8+ T cells within the liver. J Immunol 2001; 166: 5430\u20135438.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR10","doi-asserted-by":"publisher","first-page":"e1003490","DOI":"10.1371\/journal.ppat.1003490","volume":"9","author":"M Isogawa","year":"2013","unstructured":"Isogawa M, Chung J, Murata Y, Kakimi K, Chisari FV . CD40 activation rescues antiviral CD8(+) T cells from PD-1-mediated exhaustion. PLoS Pathog 2013; 9: e1003490.","journal-title":"PLoS Pathog"},{"key":"BFcmi20164_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","volume":"10","author":"AW Thomson","year":"2010","unstructured":"Thomson AW, Knolle PA . Antigen-presenting cell function in the tolerogenic liver environment. Nat Rev Immunol 2010; 10: 753\u2013766.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi20164_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2010.10.005","volume":"54","author":"IN Crispe","year":"2011","unstructured":"Crispe IN . Liver antigen-presenting cells. J Hepatol 2011; 54: 357\u2013365.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jhep.2007.01.007","volume":"46","author":"M Iannacone","year":"2007","unstructured":"Iannacone M, Sitia G, Ruggeri ZM, Guidotti LG . HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol 2007; 46: 719\u2013726.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010; 51: 81\u201391.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1053\/j.gastro.2011.06.051","volume":"141","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Cobleigh MA, Lian JQ, Huang CX, Booth CJ, Bai XF et al. A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 2011; 141: 1897\u20131906.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","volume":"177","author":"D Xu","year":"2006","unstructured":"Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177: 739\u2013747.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jmii.2013.11.001","volume":"48","author":"C Shen","year":"2015","unstructured":"Shen C, Yan WZ, Zhao CY, Che HH, Liu XY, Liu ZZ et al. Increased CD4+CD25+ regulatory T cells correlate with poor short-term outcomes in hepatitis B virus-related acute-on-chronic liver failure patients. J Microbiol Immunol Infect 2015; 48: 137\u2013146.","journal-title":"J Microbiol Immunol Infect"},{"key":"BFcmi20164_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77: 68\u201376.","journal-title":"J Virol"},{"key":"BFcmi20164_CR19","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.1073\/pnas.0504273102","volume":"102","author":"SF Wieland","year":"2005","unstructured":"Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV . Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci USA 2005; 102: 9913\u20139917.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi20164_CR20","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1128\/JVI.76.7.3570-3574.2002","volume":"76","author":"MD Robek","year":"2002","unstructured":"Robek MD, Wieland SF, Chisari FV . Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol 2002; 76: 3570\u20133574.","journal-title":"J Virol"},{"key":"BFcmi20164_CR21","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","volume":"74","author":"SF Wieland","year":"2000","unstructured":"Wieland SF, Guidotti LG, Chisari FV . Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 2000; 74: 4165\u20134173.","journal-title":"J Virol"},{"key":"BFcmi20164_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.immuni.2005.05.005","volume":"23","author":"M Isogawa","year":"2005","unstructured":"Isogawa M, Furuichi Y, Chisari FV . Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 2005; 23: 53\u201363.","journal-title":"Immunity"},{"key":"BFcmi20164_CR23","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1128\/JVI.80.7.3532-3540.2006","volume":"80","author":"T Boettler","year":"2006","unstructured":"Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, Blum HE et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 2006; 80: 3532\u20133540.","journal-title":"J Virol"},{"key":"BFcmi20164_CR24","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T et al. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007; 81: 4215\u20134225.","journal-title":"J Virol"},{"key":"BFcmi20164_CR25","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1128\/JVI.79.5.3016-3027.2005","volume":"79","author":"M Chen","year":"2005","unstructured":"Chen M, Sallberg M, Hughes J, Jones J, Guidotti LG, Chisari FV et al. Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 2005; 79: 3016\u20133027.","journal-title":"J Virol"},{"key":"BFcmi20164_CR26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","volume":"143","author":"C Boni","year":"2012","unstructured":"Boni C, Laccabue D, Lampertico P, Giuberti T, Vigano M, Schivazappa S et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology 2012; 143: 963\u2013973.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR27","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/jhep.2001.23045","volume":"33","author":"C Boni","year":"2001","unstructured":"Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33: 963\u2013971.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR28","doi-asserted-by":"crossref","unstructured":"Kong X, Sun R, Chen Y, Wei H, Tian Z . gammadeltaT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance. In J Immunol 2014, 1645\u20131653.","DOI":"10.4049\/jimmunol.1303432"},{"key":"BFcmi20164_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2249.2011.04445.x","volume":"166","author":"S Chen","year":"2011","unstructured":"Chen S, Akbar SM, Abe M, Hiasa Y, Onji M . Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus. Clin Exp Immunol 2011; 166: 134\u2013142.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR30","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","volume":"143","author":"P Fisicaro","year":"2012","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Ravanetti L, Urbani S et al. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV. Gastroenterology 2012; 143: 1576\u20131585.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR31","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.23936","volume":"52","author":"B Raziorrouh","year":"2010","unstructured":"Raziorrouh B, Schraut W, Gerlach T, Nowack D, Gruner NH, Ulsenheimer A et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 2010; 52: 1934\u20131947.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","volume":"138","author":"P Fisicaro","year":"2010","unstructured":"Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2010; 138: 682\u2013693.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR33","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","volume":"61","author":"B Bengsch","year":"2014","unstructured":"Bengsch B, Martin B, Thimme R . Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 2014; 61: 1212\u20131219.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR34","doi-asserted-by":"publisher","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","volume":"7","author":"G Nebbia","year":"2012","unstructured":"Nebbia G, Peppa D, Schurich A, Khanna P, Singh HD, Cheng Y et al. Upregulation of the Tim-3\/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS One 2012; 7: e47648.","journal-title":"PLoS One"},{"key":"BFcmi20164_CR35","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/hep.26938","volume":"59","author":"JS Dolina","year":"2014","unstructured":"Dolina JS, Braciale TJ, Hahn YS . Liver-primed CD8+ T cells suppress antiviral adaptive immunity through galectin-9-independent T-cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice. Hepatology 2014; 59: 1351\u20131365.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR36","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI33402","volume":"118","author":"AR Lopes","year":"2008","unstructured":"Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008; 118: 1835\u20131845.","journal-title":"J Clin Invest"},{"key":"BFcmi20164_CR37","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/hep.24249","volume":"53","author":"A Schurich","year":"2011","unstructured":"Schurich A, Khanna P, Lopes AR, Han KJ, Peppa D, Micco L et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection. Hepatology 2011; 53: 1494\u20131503.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR38","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/nm.3408","volume":"19","author":"SH Park","year":"2013","unstructured":"Park SH, Veerapu NS, Shin EC, Biancotto A, McCoy JP, Capone S et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med 2013; 19: 1638\u20131642.","journal-title":"Nat Med"},{"key":"BFcmi20164_CR39","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1126\/science.1088774","volume":"302","author":"A Grakoui","year":"2003","unstructured":"Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003; 302: 659\u2013662.","journal-title":"Science"},{"key":"BFcmi20164_CR40","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1128\/JVI.01581-07","volume":"82","author":"S Smyk-Pearson","year":"2008","unstructured":"Smyk-Pearson S, Tester IA, Klarquist J, Palmer BE, Pawlotsky JM, Golden-Mason L et al. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J Virol 2008; 82: 1827\u20131837.","journal-title":"J Virol"},{"key":"BFcmi20164_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/hep.20669","volume":"41","author":"N Semmo","year":"2005","unstructured":"Semmo N, Day CL, Ward SM, Lucas M, Harcourt G, Loughry A et al. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 2005; 41: 1019\u20131028.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR42","doi-asserted-by":"publisher","first-page":"e1003422","DOI":"10.1371\/journal.ppat.1003422","volume":"9","author":"H Kared","year":"2013","unstructured":"Kared H, Fabre T, Bedard N, Bruneau J, Shoukry NH . Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog 2013; 9: e1003422.","journal-title":"PLoS Pathog"},{"key":"BFcmi20164_CR43","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/hep.21242","volume":"44","author":"S Urbani","year":"2006","unstructured":"Urbani S, Amadei B, Fisicaro P, Tola D, Orlandini A, Sacchelli L et al. Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses. Hepatology 2006; 44: 126\u2013139.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR44","doi-asserted-by":"publisher","first-page":"e649","DOI":"10.1371\/journal.pone.0000649","volume":"2","author":"M Lucas","year":"2007","unstructured":"Lucas M, Ulsenheimer A, Pfafferot K, Heeg MH, Gaudieri S, Gruner N et al. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PLoS One 2007; 2: e649.","journal-title":"PLoS One"},{"key":"BFcmi20164_CR45","first-page":"1437","volume":"38","author":"K Sugimoto","year":"2003","unstructured":"Sugimoto K, Ikeda F, Stadanlick J, Nunes FA, Alter HJ, Chang KM . Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 2003; 38: 1437\u20131448.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR46","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.1128\/JVI.79.12.7860-7867.2005","volume":"79","author":"T Boettler","year":"2005","unstructured":"Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005; 79: 7860\u20137867.","journal-title":"J Virol"},{"key":"BFcmi20164_CR47","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.molimm.2014.09.015","volume":"63","author":"X Hou","year":"2015","unstructured":"Hou X, Song J, Su J, Huang D, Gao W, Yan J et al. CD4(+)Foxp3(+) Tregs protect against innate immune cell-mediated fulminant hepatitis in mice. Mol Immunol 2015; 63: 420\u2013427.","journal-title":"Mol Immunol"},{"key":"BFcmi20164_CR48","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1053\/j.gastro.2011.05.006","volume":"141","author":"EC Shin","year":"2011","unstructured":"Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, Major M et al. Delayed induction, not impaired recruitment, of specific CD8(+) T cells causes the late onset of acute hepatitis C. Gastroenterology 2011; 141: 686\u2013695.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1084\/jem.20030239","volume":"197","author":"NH Shoukry","year":"2003","unstructured":"Shoukry NH, Grakoui A, Houghton M, Chien DY, Ghrayeb J, Reimann KA et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003; 197: 1645\u20131655.","journal-title":"J Exp Med"},{"key":"BFcmi20164_CR50","doi-asserted-by":"publisher","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","volume":"6","author":"B Bengsch","year":"2010","unstructured":"Bengsch B, Seigel B, Ruhl M, Timm J, Kuntz M, Blum HE et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010; 6: e1000947.","journal-title":"PLoS Pathog"},{"key":"BFcmi20164_CR51","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/hep.20856","volume":"42","author":"HC Spangenberg","year":"2005","unstructured":"Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M et al. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 2005; 42: 828\u2013837.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR52","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.169.6.3447","volume":"169","author":"H Wedemeyer","year":"2002","unstructured":"Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002; 169: 3447\u20133458.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR53","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2014.05.043","volume":"61","author":"B Martin","year":"2014","unstructured":"Martin B, Hennecke N, Lohmann V, Kayser A, Neumann-Haefelin C, Kukolj G et al. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. J Hepatol 2014; 61: 538\u2013543.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR54","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1172\/JCI200420515","volume":"113","author":"D Accapezzato","year":"2004","unstructured":"Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004; 113: 963\u2013972.","journal-title":"J Clin Invest"},{"key":"BFcmi20164_CR55","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1128\/JVI.02474-07","volume":"82","author":"V Kasprowicz","year":"2008","unstructured":"Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, Nolan BE, Longworth S, Berical A et al. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 2008; 82: 3154\u20133160.","journal-title":"J Virol"},{"key":"BFcmi20164_CR56","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","volume":"81","author":"H Radziewicz","year":"2007","unstructured":"Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007; 81: 2545\u20132553.","journal-title":"J Virol"},{"key":"BFcmi20164_CR57","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/hep.21541","volume":"45","author":"A Penna","year":"2007","unstructured":"Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L et al. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007; 45: 588\u2013601.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR58","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.1128\/JVI.00409-07","volume":"81","author":"L Golden-Mason","year":"2007","unstructured":"Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR . Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007; 81: 9249\u20139258.","journal-title":"J Virol"},{"key":"BFcmi20164_CR59","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1172\/JCI43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010; 120: 4546\u20134557.","journal-title":"J Clin Invest"},{"key":"BFcmi20164_CR60","doi-asserted-by":"publisher","first-page":"9122","DOI":"10.1128\/JVI.00639-09","volume":"83","author":"L Golden-Mason","year":"2009","unstructured":"Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ et al. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009; 83: 9122\u20139130.","journal-title":"J Virol"},{"key":"BFcmi20164_CR61","doi-asserted-by":"publisher","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","volume":"5","author":"N Nakamoto","year":"2009","unstructured":"Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 2009; 5: e1000313.","journal-title":"PLoS Pathog"},{"key":"BFcmi20164_CR62","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jcv.2014.12.014","volume":"64","author":"S May","year":"2015","unstructured":"May S, Ngui SL, Collins S, Lattimore S, Ramsay M, Tedder RS et al. Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis. J Clin Virol 2015; 64: 6\u201311.","journal-title":"J Clin Virol"},{"key":"BFcmi20164_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2014.09.001","volume":"24","author":"KJ Lafaro","year":"2015","unstructured":"Lafaro KJ, Demirjian AN, Pawlik TM . Epidemiology of hepatocellular carcinoma. Surg Oncol Clin N Am 2015; 24: 1\u201317.","journal-title":"Surg Oncol Clin N Am"},{"key":"BFcmi20164_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/jgh.12010","volume":"28","author":"CL Lin","year":"2013","unstructured":"Lin CL, Kao JH . Risk stratification for hepatitis B virus related hepatocellular carcinoma. J Gastroenterol Hepatol 2013; 28: 10\u201317.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcmi20164_CR65","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1517\/14712598.2010.529125","volume":"10","author":"C Miroux","year":"2010","unstructured":"Miroux C, Vausselin T, Delhem N . Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response. Expert Opin Biol Ther 2010; 10: 1563\u20131572.","journal-title":"Expert Opin Biol Ther"},{"key":"BFcmi20164_CR66","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/jgh.12202","volume":"28","author":"H Wu","year":"2013","unstructured":"Wu H, Chen P, Liao R, Li YW, Yi Y, Wang JX et al. Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients. J Gastroenterol Hepatol 2013; 28: 1555\u20131564.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcmi20164_CR67","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jhep.2005.12.027","volume":"45","author":"E Unitt","year":"2006","unstructured":"Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006; 45: 246\u2013253.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR68","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/hep.22535","volume":"48","author":"R Thimme","year":"2008","unstructured":"Thimme R, Neagu M, Boettler T, Neumann-Haefelin C, Kersting N, Geissler M et al. Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma. Hepatology 2008; 48: 1821\u20131833.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR69","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/icb.2013.38","volume":"91","author":"H Harimoto","year":"2013","unstructured":"Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C et al. Inactivation of tumor-specific CD8(+) CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol 2013; 91: 545\u2013555.","journal-title":"Immunol Cell Biol"},{"key":"BFcmi20164_CR70","doi-asserted-by":"publisher","first-page":"6287","DOI":"10.3748\/wjg.v20.i20.6287","volume":"20","author":"L Carulli","year":"2014","unstructured":"Carulli L, Anzivino C . Telomere and telomerase in chronic liver disease and hepatocarcinoma. World J Gastroenterol 2014; 20: 6287\u20136292.","journal-title":"World J Gastroenterol"},{"key":"BFcmi20164_CR71","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1158\/1078-0432.CCR-09-2214","volume":"16","author":"R Satow","year":"2010","unstructured":"Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T et al. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res 2010; 16: 2518\u20132528.","journal-title":"Clin Cancer Res"},{"key":"BFcmi20164_CR72","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1158\/1078-0432.CCR-05-2267","volume":"12","author":"H Komori","year":"2006","unstructured":"Komori H, Nakatsura T, Senju S, Yoshitake Y, Motomura Y, Ikuta Y et al. Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma. Clin Cancer Res 2006; 12: 2689\u20132697.","journal-title":"Clin Cancer Res"},{"key":"BFcmi20164_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3892\/ol.2011.441","volume":"3","author":"H Xu","year":"2012","unstructured":"Xu H, Gu N, Liu ZB, Zheng M, Xiong F, Wang SY et al. NY-ESO-1 expression in hepatocellular carcinoma: a potential new marker for early recurrence after surgery. Oncol Lett 2012; 3: 39\u201344.","journal-title":"Oncol Lett"},{"key":"BFcmi20164_CR74","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.4049\/jimmunol.174.3.1709","volume":"174","author":"G Bricard","year":"2005","unstructured":"Bricard G, Bouzourene H, Martinet O, Rimoldi D, Halkic N, Gillet M et al. Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma. J Immunol 2005; 174: 1709\u20131716.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR75","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.humimm.2010.09.011","volume":"71","author":"ZQ Yang","year":"2010","unstructured":"Yang ZQ, Yang ZY, Zhang LD, Ping B, Wang SG, Ma KS et al. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Hum Immunol 2010; 71: 1180\u20131186.","journal-title":"Hum Immunol"},{"key":"BFcmi20164_CR76","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-05-0382","volume":"11","author":"A Alisa","year":"2005","unstructured":"Alisa A, Ives A, Pathan AA, Navarrete CV, Williams R, Bertoletti A et al. Analysis of CD4+ T-Cell responses to a novel alpha-fetoprotein-derived epitope in hepatocellular carcinoma patients. Clin Cancer Res 2005; 11: 6686\u20136694.","journal-title":"Clin Cancer Res"},{"key":"BFcmi20164_CR77","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/ijc.25866","volume":"129","author":"M Witkowski","year":"2011","unstructured":"Witkowski M, Spangenberg HC, Neumann-Haefelin C, Buttner N, Breous E, Kersting N et al. Lack of ex vivo peripheral and intrahepatic alpha-fetoprotein-specific CD4+ responses in hepatocellular carcinoma. Int J Cancer 2011; 129: 2171\u20132182.","journal-title":"Int J Cancer"},{"key":"BFcmi20164_CR78","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1158\/0008-5472.CAN-12-3381","volume":"73","author":"S Kalathil","year":"2013","unstructured":"Kalathil S, Lugade AA, Miller A, Iyer R, Thanavala Y . Higher frequencies of GARP(+)CTLA-4(+)Foxp3(+) T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T-cell functionality. Cancer Res 2013; 73: 2435\u20132444.","journal-title":"Cancer Res"},{"key":"BFcmi20164_CR79","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1078-0432.CCR-06-2363","volume":"13","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Hiraoka N, Yamagami W, Ojima H, Kanai Y, Kosuge T et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res 2007; 13: 902\u2013911.","journal-title":"Clin Cancer Res"},{"key":"BFcmi20164_CR80","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.20644","volume":"41","author":"E Unitt","year":"2005","unstructured":"Unitt E, Rushbrook SM, Marshall A, Davies S, Gibbs P, Morris LS et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 2005; 41: 722\u2013730.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/CJI.0b013e3181bb499f","volume":"33","author":"TF Greten","year":"2010","unstructured":"Greten TF, Ormandy LA, Fikuart A, Hochst B, Henschen S, Horning M et al. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC. J Immunother 2010; 33: 211\u2013218.","journal-title":"J Immunother"},{"key":"BFcmi20164_CR82","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/S1473-3099(07)70289-X","volume":"7","author":"T Manigold","year":"2007","unstructured":"Manigold T, Racanelli V . T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. Lancet Infect Dis 2007; 7: 804\u2013813.","journal-title":"Lancet Infect Dis"},{"key":"BFcmi20164_CR83","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1159\/000373976","volume":"35","author":"Y Shen","year":"2015","unstructured":"Shen Y, Wei Y, Wang Z, Jing Y, He H, Yuan J et al. TGF-beta regulates hepatocellular carcinoma progression by inducing Treg cell polarization. Cell Physiol Biochem 2015; 35: 1623\u20131632.","journal-title":"Cell Physiol Biochem"},{"key":"BFcmi20164_CR84","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/hepr.12167","volume":"44","author":"P Shen","year":"2014","unstructured":"Shen P, Wang A, He M, Wang Q, Zheng S . Increased circulating Lin(-\/low) CD33(+) HLA-DR(-) myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatol Res 2014; 44: 639\u2013650.","journal-title":"Hepatol Res"},{"key":"BFcmi20164_CR85","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jhep.2013.08.003","volume":"59","author":"J Schrader","year":"2013","unstructured":"Schrader J . The role of MDSCs in hepatocellular carcinoma\u2014in vivo veritas? J Hepatol 2013; 59: 921\u2013923.","journal-title":"J Hepatol"},{"issue":"2","key":"BFcmi20164_CR86","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/00365521.2010.516450","volume":"46","author":"Cheng-En Hu","year":"2010","unstructured":"Hu CE, Gan J, Zhang RD, Cheng YR, Huang GJ . Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function. Scand J Gastroenterol 2011, 156\u2013164.","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"3","key":"BFcmi20164_CR87","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/hep.23054","volume":"50","author":"Bastian Hoechst","year":"2009","unstructured":"Hoechst B, Voigtlaender T, Ormandy L, Gamrekelashvili J, Zhao F, Wedemeyer H et al. Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 2009, 799\u2013807.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR88","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2008.03.020","volume":"135","author":"B Hoechst","year":"2008","unstructured":"Hoechst B, Ormandy LA, Ballmaier M, Lehner F, Kruger C, Manns MP et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 2008; 135: 234\u2013243.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR89","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.26694","volume":"59","author":"Y Han","year":"2014","unstructured":"Han Y, Chen Z, Yang Y, Jiang Z, Gu Y, Liu Y et al. Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma. Hepatology 2014; 59: 567\u2013579.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR90","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","volume":"17","author":"BJ Wang","year":"2011","unstructured":"Wang BJ, Bao JJ, Wang JZ, Wang Y, Jiang M, Xing MY et al. Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma. World J Gastroenterol 2011; 17: 3322\u20133329.","journal-title":"World J Gastroenterol"},{"key":"BFcmi20164_CR91","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.25397","volume":"128","author":"F Shi","year":"2011","unstructured":"Shi F, Shi M, Zeng Z, Qi RZ, Liu ZW, Zhang JY et al. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer 2011; 128: 887\u2013896.","journal-title":"Int J Cancer"},{"key":"BFcmi20164_CR92","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.04.045","volume":"137","author":"AJ Gehring","year":"2009","unstructured":"Gehring AJ, Ho ZZ, Tan AT, Aung MO, Lee KH, Tan KC et al. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma. Gastroenterology 2009; 137: 682\u2013690.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR93","doi-asserted-by":"publisher","first-page":"e23621","DOI":"10.1371\/journal.pone.0023621","volume":"6","author":"Z Zeng","year":"2011","unstructured":"Zeng Z, Shi F, Zhou L, Zhang MN, Chen Y, Chang XJ et al. Upregulation of circulating PD-L1\/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma. PLoS One 2011; 6: e23621.","journal-title":"PLoS One"},{"key":"BFcmi20164_CR94","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/1078-0432.CCR-08-1608","volume":"15","author":"Q Gao","year":"2009","unstructured":"Gao Q, Wang XY, Qiu SJ, Yamato I, Sho M, Nakajima Y et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res 2009; 15: 971\u2013979.","journal-title":"Clin Cancer Res"},{"key":"BFcmi20164_CR95","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00535-014-0933-3","volume":"50","author":"Y Umemoto","year":"2015","unstructured":"Umemoto Y, Okano S, Matsumoto Y, Nakagawara H, Matono R, Yoshiya S et al. Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy. J Gastroenterol 2015; 50: 65\u201375.","journal-title":"J Gastroenterol"},{"key":"BFcmi20164_CR96","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1440-1746.2004.03467.x","volume":"19","author":"K Fujiwara","year":"2004","unstructured":"Fujiwara K, Higashi T, Nouso K, Nakatsukasa H, Kobayashi Y, Uemura M et al. Decreased expression of B7 costimulatory molecules and major histocompatibility complex class-I in human hepatocellular carcinoma. J Gastroenterol Hepatol 2004; 19: 1121\u20131127.","journal-title":"J Gastroenterol Hepatol"},{"key":"BFcmi20164_CR97","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1111\/liv.12488","volume":"34","author":"EI Rigopoulou","year":"2014","unstructured":"Rigopoulou EI, Bogdanos DP . Is primary biliary cirrhosis rare or common? The truth lies somewhere in between. Liver Int 2014; 34: e165\u2013e167.","journal-title":"Liver Int"},{"key":"BFcmi20164_CR98","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1055\/s-0034-1383730","volume":"34","author":"L Griffiths","year":"2014","unstructured":"Griffiths L, Dyson JK, Jones DE . The new epidemiology of primary biliary cirrhosis. Semin Liver Dis 2014; 34: 318\u2013328.","journal-title":"Semin Liver Dis"},{"key":"BFcmi20164_CR99","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.28140","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K et al. Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'. Hepatology 2015; 62: 1620\u20131622.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR100","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/s-0034-1383729","volume":"34","author":"L Wang","year":"2014","unstructured":"Wang L, Wang FS, Chang C, Gershwin ME . Breach of tolerance: primary biliary cirrhosis. Semin Liver Dis 2014; 34: 297\u2013317.","journal-title":"Semin Liver Dis"},{"key":"BFcmi20164_CR101","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cei.12298","volume":"177","author":"CH Chang","year":"2014","unstructured":"Chang CH, Chen YC, Yu YH, Tao MH, Leung PS, Ansari AA et al. Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. Clin Exp Immunol 2014; 177: 373\u2013380.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR102","doi-asserted-by":"publisher","first-page":"e0121320","DOI":"10.1371\/journal.pone.0121320","volume":"10","author":"CH Chang","year":"2015","unstructured":"Chang CH, Chen YC, Zhang W, Leung PS, Gershwin ME, Chuang YH . Innate immunity drives the initiation of a murine model of primary biliary cirrhosis. PloS One 2015; 10: e0121320.","journal-title":"PloS One"},{"key":"BFcmi20164_CR103","doi-asserted-by":"publisher","first-page":"8019","DOI":"10.1038\/ncomms9019","volume":"6","author":"HJ Cordell","year":"2015","unstructured":"Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS et al. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Nat Commun 2015; 6: 8019.","journal-title":"Nat Commun"},{"key":"BFcmi20164_CR104","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s12016-015-8472-0","volume":"48","author":"M Dong","year":"2015","unstructured":"Dong M, Li J, Tang R, Zhu P, Qiu F, Wang C et al. Multiple genetic variants associated with primary biliary cirrhosis in a Han Chinese population. Clin Rev Allergy Immunol 2015; 48: 316\u2013321.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR105","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.27253","volume":"60","author":"MJ Kurth","year":"2014","unstructured":"Kurth MJ, Yokoi T, Gershwin ME . Halothane-induced hepatitis: paradigm or paradox for drug-induced liver injury. Hepatology 2014; 60: 1473\u20131475.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","volume":"7","author":"A Lleo","year":"2015","unstructured":"Lleo A, Zhang W, Zhao M, Tan Y, Bernuzzi F, Zhu B et al. DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis. Clin Epigenetics 2015; 7: 61.","journal-title":"Clin Epigenetics"},{"key":"BFcmi20164_CR107","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/liv.12690","volume":"35","author":"GL Norman","year":"2015","unstructured":"Norman GL, Yang CY, Ostendorff HP, Shums Z, Lim MJ, Wang J et al. Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis. Liver Int 2015; 35: 642\u2013651.","journal-title":"Liver Int"},{"key":"BFcmi20164_CR108","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1309\/AJCPQV4A7QAEEFEV","volume":"144","author":"MM Tana","year":"2015","unstructured":"Tana MM, Shums Z, Milo J, Norman GL, Leung PS, Gershwin ME et al. The significance of autoantibody changes over time in primary biliary cirrhosis. Am J Clin Pathol 2015; 144: 601\u2013606.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"BFcmi20164_CR109","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/cmi.2015.86","volume":"14","author":"Takashi Tomiyama","year":"2015","unstructured":"Tomiyama T, Yang GX, Zhao M, Zhang W, Tanaka H, Wang J et al. The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis. Cell MolI Immunol 2015 e-pub ahead of print 21 September 2015 doi:10.1038\/cmi.2015.86.","journal-title":"Cellular & Molecular Immunology"},{"key":"BFcmi20164_CR110","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1055\/s-0034-1383728","volume":"34","author":"J Wang","year":"2014","unstructured":"Wang J, Yang GX, Tsuneyama K, Gershwin ME, Ridgway WM, Leung PS . Animal models of primary biliary cirrhosis. Semin Liver Dis 2014; 34: 285\u2013296.","journal-title":"Semin Liver Dis"},{"key":"BFcmi20164_CR111","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.27725","volume":"61","author":"Y Li","year":"2015","unstructured":"Li Y, Wang W, Tang L, He X, Yan X, Zhang X et al. Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis. Hepatology 2015; 61: 1998\u20132007.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR112","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hep.27230","volume":"60","author":"A Lleo","year":"2014","unstructured":"Lleo A, Zhang W, McDonald WH, Seeley EH, Leung PS, Coppel RL et al. Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 2014; 60: 1314\u20131323.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR113","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1002\/hep.27313","volume":"60","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014; 60: 1708\u20131716.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR114","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/hep.23783","volume":"52","author":"A Lleo","year":"2010","unstructured":"Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010; 52: 987\u2013998.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR115","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/hep.24355","volume":"54","author":"G Rong","year":"2011","unstructured":"Rong G, Zhong R, Lleo A, Leung PS, Bowlus CL, Yang GX et al. Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis. Hepatology 2011; 54: 196\u2013203.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR116","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1084\/jem.20010956","volume":"195","author":"H Kita","year":"2002","unstructured":"Kita H, Lian ZX, Van de Water J, He XS, Matsumura S, Kaplan M et al. Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med 2002; 195: 113\u2013123.","journal-title":"J Exp Med"},{"key":"BFcmi20164_CR117","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0090-1229(86)90049-8","volume":"41","author":"G Colucci","year":"1986","unstructured":"Colucci G, Schaffner F, Paronetto F . In situ characterization of the cell-surface antigens of the mononuclear cell infiltrate and bile duct epithelium in primary biliary cirrhosis. Clin Immunol Immunopathol 1986; 41: 35\u201342.","journal-title":"Clin Immunol Immunopathol"},{"key":"BFcmi20164_CR118","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI0214698","volume":"109","author":"H Kita","year":"2002","unstructured":"Kita H, Matsumura S, He XS, Ansari AA, Lian ZX, Van de Water J et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109: 1231\u20131240.","journal-title":"J Clin Invest"},{"key":"BFcmi20164_CR119","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2249.2008.03837.x","volume":"155","author":"K Wakabayashi","year":"2009","unstructured":"Wakabayashi K, Yoshida K, Leung PS, Moritoki Y, Yang GX, Tsuneyama K et al. Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization. Clin Exp Immunol 2009; 155: 577\u2013586.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR120","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/hep.22390","volume":"48","author":"K Wakabayashi","year":"2008","unstructured":"Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ et al. Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology 2008; 48: 531\u2013540.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR121","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1365-2249.2011.04453.x","volume":"166","author":"YM Ambrosini","year":"2011","unstructured":"Ambrosini YM, Yang GX, Zhang W, Tsuda M, Shu S, Tsuneyama K et al. The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis. Clin Exp Immunol 2011; 166: 110\u2013120.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR122","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/hep.22226","volume":"47","author":"GX Yang","year":"2008","unstructured":"Yang GX, Lian ZX, Chuang YH, Moritoki Y, Lan RY, Wakabayashi K et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008; 47: 1974\u20131982.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR123","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I et al. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology 2008; 134: 1482\u20131493.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR124","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","volume":"51","author":"Y Yao","year":"2014","unstructured":"Yao Y, Yang W, Yang YQ, Ma HD, Lu FT, Li L et al. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-\/-) mice. Journal of autoimmunity 2014; 51: 99\u2013108.","journal-title":"Journal of autoimmunity"},{"key":"BFcmi20164_CR125","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.22591","volume":"49","author":"W Hsu","year":"2009","unstructured":"Hsu W, Zhang W, Tsuneyama K, Moritoki Y, Ridgway WM, Ansari AA et al. Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice. Hepatology 2009; 49: 133\u2013140.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR126","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/hep.26418","volume":"58","author":"K Kawata","year":"2013","unstructured":"Kawata K, Yang GX, Ando Y, Tanaka H, Zhang W, Kobayashi Y et al. Clonality, activated antigen-specific CD8(+) T cells, and development of autoimmune cholangitis in dnTGFbetaRII mice. Hepatology 2013; 58: 1094\u20131104.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR127","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1084\/jem.181.5.1835","volume":"181","author":"S Shimoda","year":"1995","unstructured":"Shimoda S, Nakamura M, Ishibashi H, Hayashida K, Niho Y . HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases. J Exp Med 1995; 181: 1835\u20131845.","journal-title":"J Exp Med"},{"key":"BFcmi20164_CR128","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.181.2.723","volume":"181","author":"J Van de Water","year":"1995","unstructured":"Van de Water J, Ansari A, Prindiville T, Coppel RL, Ricalton N, Kotzin BL et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 1995; 181: 723\u2013733.","journal-title":"J Exp Med"},{"key":"BFcmi20164_CR129","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jaut.2008.05.003","volume":"31","author":"S Shimoda","year":"2008","unstructured":"Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H et al. CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun 2008; 31: 110\u2013115.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR130","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jaut.2008.11.001","volume":"32","author":"RY Lan","year":"2009","unstructured":"Lan RY, Salunga TL, Tsuneyama K, Lian ZX, Yang GX, Hsu W et al. Hepatic IL-17 responses in human and murine primary biliary cirrhosis. J Autoimmun 2009; 32: 43\u201351.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR131","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/hep.26979","volume":"59","author":"CY Yang","year":"2014","unstructured":"Yang CY, Ma X, Tsuneyama K, Huang S, Takahashi T, Chalasani NP et al. IL-12\/Th1 and IL-23\/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014; 59: 1944\u20131953.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR132","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.21123","volume":"43","author":"RY Lan","year":"2006","unstructured":"Lan RY, Cheng C, Lian ZX, Tsuneyama K, Yang GX, Moritoki Y et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 2006; 43: 729\u2013737.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR133","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","volume":"27","author":"CA Aoki","year":"2006","unstructured":"Aoki CA, Roifman CM, Lian ZX, Bowlus CL, Norman GL, Shoenfeld Y et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 2006; 27: 50\u201353.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR134","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12415","volume":"178","author":"H Tanaka","year":"2014","unstructured":"Tanaka H, Zhang W, Yang GX, Ando Y, Tomiyama T, Tsuneyama K et al. Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells. Clin Exp Immunol 2014; 178: 253\u2013261.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR135","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","volume":"50","author":"W Huang","year":"2014","unstructured":"Huang W, Kachapati K, Adams D, Wu Y, Leung PS, Yang GX et al. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun 2014; 50: 123\u2013134.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR136","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","volume":"59","author":"YH Wang","year":"2015","unstructured":"Wang YH, Yang W, Yang JB, Jia YJ, Tang W, Gershwin ME et al. Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun 2015; 59: 26\u201337.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR137","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jaut.2015.09.002","volume":"66","author":"JB Yang","year":"2015","unstructured":"Yang JB, Wang YH, Yang W, Lu FT, Ma HD, Zhao ZB et al. Successful treatment of murine autoimmune cholangitis by parabiosis: Implications for hematopoietic therapy. J Autoimmun 2015; 66: 108\u2013117.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR138","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10620-014-3372-3","volume":"60","author":"L Wang","year":"2015","unstructured":"Wang L, Sun X, Qiu J, Cai Y, Ma L, Zhao P et al. Increased numbers of circulating ICOS(+) follicular helper T and CD38(+) plasma cells in patients with newly diagnosed primary biliary cirrhosis. Dig Dis Sci 2015; 60: 405\u2013413.","journal-title":"Dig Dis Sci"},{"key":"BFcmi20164_CR139","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/hep.27306","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Sun Y, Zhang Z, Jia Y, Zou Z, Ding J et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 2015; 61: 627\u2013638.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR140","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00281-009-0172-5","volume":"31","author":"YH Chuang","year":"2009","unstructured":"Chuang YH, Lan RY, Gershwin ME . The immunopathology of human biliary cell epithelium. Semin Immunopathol 2009; 31: 323\u2013331.","journal-title":"Semin Immunopathol"},{"key":"BFcmi20164_CR141","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.23318","volume":"51","author":"S Shimoda","year":"2010","unstructured":"Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K et al. CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology 2010; 51: 567\u2013575.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR142","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/hep.22011","volume":"47","author":"EB Alabraba","year":"2008","unstructured":"Alabraba EB, Lai V, Boon L, Wigmore SJ, Adams DH, Afford SC . Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion. Hepatology 2008; 47: 552\u2013562.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"BFcmi20164_CR143","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00535-010-0303-8","volume":"46","author":"A Lleo","year":"2011","unstructured":"Lleo A, Shimoda S, Ishibashi H, Gershwin ME . Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2011; 46 (Suppl 1): 29\u201338.","journal-title":"J Gastroenterol"},{"key":"BFcmi20164_CR144","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.24630","volume":"55","author":"A Lleo","year":"2012","unstructured":"Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. Hepatology 2012; 55: 153\u2013160.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR145","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/cei.12193","volume":"174","author":"H Tanaka","year":"2013","unstructured":"Tanaka H, Yang GX, Iwakoshi N, Knechtle SJ, Kawata K, Tsuneyama K et al. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 2013; 174: 364\u2013371.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi20164_CR146","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/hep.26067","volume":"57","author":"A Dhirapong","year":"2013","unstructured":"Dhirapong A, Yang GX, Nadler S, Zhang W, Tsuneyama K, Leung P et al. Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis. Hepatology 2013; 57: 708\u2013715.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR147","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P et al. Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 192\u2013197.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR148","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.dld.2015.02.002","volume":"47","author":"A Floreani","year":"2015","unstructured":"Floreani A, Motta R, Cazzagon N, Franceschet I, Roncalli M, Del Ross T et al. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Dig Liver Dis 2015; 47: 432\u2013435.","journal-title":"Dig Liver Dis"},{"key":"BFcmi20164_CR149","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12016-014-8446-7","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Spinazze A, Caballeria L, Reig A, Cazzagon N, Franceschet I et al. Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol 2015; 48: 254\u2013262.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR150","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, Wang H, Bowlus CL, Wang C, Lu Y, Zeng Z et al. Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol 2015; 48: 132\u2013141.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR151","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-014-8439-6","volume":"47","author":"X Huang","year":"2014","unstructured":"Huang X, Wu H, Lu Q . The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 2014; 47: 219\u2013233.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2015.08.015","volume":"64","author":"MF Seldin","year":"2015","unstructured":"Seldin MF . The genetics of human autoimmune disease: a perspective on progress in the field and future directions. J Autoimmun 2015; 64: 1\u201312.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR153","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2015.08.016","volume":"66","author":"GJ Webb","year":"2015","unstructured":"Webb GJ, Hirschfield GM . Using GWAS to identify genetic predisposition in hepatic autoimmunity. J Autoimmun 2015; 66: 25\u201339.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR154","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jaut.2015.07.004","volume":"64","author":"GJ Webb","year":"2015","unstructured":"Webb GJ, Siminovitch KA, Hirschfield GM . The immunogenetics of primary biliary cirrhosis: a comprehensive review. J Autoimmun 2015; 64: 42\u201352.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR155","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12016-015-8484-9","volume":"48","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME . Unmet challenges in immune-mediated hepatobiliary diseases. Clin Rev Allergy Immunol 2015; 48: 127\u2013131.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR156","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","volume":"19","author":"AJ Czaja","year":"2015","unstructured":"Czaja AJ . Diagnosis and management of autoimmune hepatitis. Clin Liver Dis 2015; 19: 57\u201379.","journal-title":"Clin Liver Dis"},{"key":"BFcmi20164_CR157","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1007\/s10620-011-1769-9","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ . Cryptogenic chronic hepatitis and its changing guise in adults. Dig Dis Sci 2011; 56: 3421\u20133438.","journal-title":"Dig Dis Sci"},{"key":"BFcmi20164_CR158","first-page":"222","volume":"6","author":"EL Cancado","year":"2015","unstructured":"Cancado EL, Abrantes-Lemos CP, Terrabuio DR . The importance of autoantibody detection in autoimmune hepatitis. Front Immunol 2015; 6: 222.","journal-title":"Front Immunol"},{"key":"BFcmi20164_CR159","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jaut.2012.11.002","volume":"41","author":"R Liberal","year":"2013","unstructured":"Liberal R, Grant CR, Mieli-Vergani G, Vergani D . Autoimmune hepatitis: a comprehensive review. J Autoimmun 2013; 41: 126\u2013139.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR160","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","volume":"61","author":"R Taubert","year":"2014","unstructured":"Taubert R, Hardtke-Wolenski M, Noyan F, Wilms A, Baumann AK, Schlue J et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies. J Hepatol 2014; 61: 1106\u20131114.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR161","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","volume":"48","author":"Q Miao","year":"2015","unstructured":"Miao Q, Bian Z, Tang R, Zhang H, Wang Q, Huang S et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015; 48: 226\u2013235.","journal-title":"Clin Rev Allergy Immunol"},{"key":"BFcmi20164_CR162","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.27087","volume":"60","author":"A Ikeda","year":"2014","unstructured":"Ikeda A, Aoki N, Kido M, Iwamoto S, Nishiura H, Maruoka R et al. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice. Hepatology 2014; 60: 224\u2013236.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR163","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1053\/j.gastro.2011.01.002","volume":"140","author":"N Aoki","year":"2011","unstructured":"Aoki N, Kido M, Iwamoto S, Nishiura H, Maruoka R, Tanaka J et al. Dysregulated generation of follicular helper T cells in the spleen triggers fatal autoimmune hepatitis in mice. Gastroenterology 2011; 140: 1322\u20131333.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR164","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","volume":"135","author":"M Kido","year":"2008","unstructured":"Kido M, Watanabe N, Okazaki T, Akamatsu T, Tanaka J, Saga K et al. Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling. Gastroenterology 2008; 135: 1333\u20131343.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR165","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","volume":"176","author":"MS Longhi","year":"2006","unstructured":"Longhi MS, Hussain MJ, Mitry RR, Arora SK, Mieli-Vergani G, Vergani D et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 2006; 176: 4484\u20134491.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR166","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.25682","volume":"56","author":"R Liberal","year":"2012","unstructured":"Liberal R, Grant CR, Holder BS, Ma Y, Mieli-Vergani G, Vergani D et al. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway. Hepatology 2012; 56: 677\u2013686.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR167","doi-asserted-by":"publisher","first-page":"e18909","DOI":"10.1371\/journal.pone.0018909","volume":"6","author":"L Zhao","year":"2011","unstructured":"Zhao L, Tang Y, You Z, Wang Q, Liang S, Han X et al. Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 2011; 6: e18909.","journal-title":"PLoS One"},{"key":"BFcmi20164_CR168","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fimmu.2014.00046","volume":"5","author":"BD Singer","year":"2014","unstructured":"Singer BD, King LS, D'Alessio FR . Regulatory T cells as immunotherapy. Front Immunol 2014; 5: 46.","journal-title":"Front Immunol"},{"key":"BFcmi20164_CR169","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2013.03.011","volume":"145","author":"R Maruoka","year":"2013","unstructured":"Maruoka R, Aoki N, Kido M, Iwamoto S, Nishiura H, Ikeda A et al. Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis. Gastroenterology 2013; 145: 209\u2013220.","journal-title":"Gastroenterology"},{"key":"BFcmi20164_CR170","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","volume":"110","author":"G Borsellino","year":"2007","unstructured":"Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225\u20131232.","journal-title":"Blood"},{"key":"BFcmi20164_CR171","doi-asserted-by":"publisher","first-page":"6780","DOI":"10.4049\/jimmunol.177.10.6780","volume":"177","author":"JJ Kobie","year":"2006","unstructured":"Kobie JJ, Shah PR, Yang L, Rebhahn JA, Fowell DJ, Mosmann TR . T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine. J Immunol 2006; 177: 6780\u20136786.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR172","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257\u20131265.","journal-title":"J Exp Med"},{"key":"BFcmi20164_CR173","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.26583","volume":"59","author":"CR Grant","year":"2014","unstructured":"Grant CR, Liberal R, Holder BS, Cardone J, Ma Y, Robson SC et al. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis. Hepatology 2014; 59: 1007\u20131015.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR174","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","volume":"41","author":"MS Longhi","year":"2004","unstructured":"Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D . Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. J Hepatol 2004; 41: 31\u201337.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR175","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","volume":"52","author":"S Ferri","year":"2010","unstructured":"Ferri S, Longhi MS, De Molo C, Lalanne C, Muratori P, Granito A et al. A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis. Hepatology 2010; 52: 999\u20131007.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR176","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","volume":"57","author":"M Peiseler","year":"2012","unstructured":"Peiseler M, Sebode M, Franke B, Wortmann F, Schwinge D, Quaas A et al. FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol 2012; 57: 125\u2013132.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR177","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jaut.2013.06.016","volume":"46","author":"L Muratori","year":"2013","unstructured":"Muratori L, Longhi MS . The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies. J Autoimmun 2013; 46: 74\u201380.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR178","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4291\/wjgp.v5.i2.107","volume":"5","author":"L Hammerich","year":"2014","unstructured":"Hammerich L, Tacke F . Role of gamma-delta T cells in liver inflammation and fibrosis. World J Gastrointest Pathophysiol 2014; 5: 107\u2013113.","journal-title":"World J Gastrointest Pathophysiol"},{"key":"BFcmi20164_CR179","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/hep.28001","volume":"62","author":"X Liu","year":"2015","unstructured":"Liu X, Jiang X, Liu R, Wang L, Qian T, Zheng Y et al. B cells expressing CD11b effectively inhibit CD4+ T-cell responses and ameliorate experimental autoimmune hepatitis in mice. Hepatology 2015; 62: 1563\u20131575.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR180","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/jmcb\/mjv048","volume":"7","author":"L Bai","year":"2015","unstructured":"Bai L, Zhang W, Tan L, Yang H, Ge M, Zhu C et al. Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication. J. Mol Cell Biol 2015; 7: 543\u2013556.","journal-title":"Mol Cell Biol"},{"key":"BFcmi20164_CR181","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3748\/wjg.v21.i13.3786","volume":"21","author":"DR Yang","year":"2015","unstructured":"Yang DR, Zhu HZ . Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war? World J Gastroenterol 2015; 21: 3786\u20133800.","journal-title":"World J Gastroenterol"},{"key":"BFcmi20164_CR182","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.antiviral.2014.11.009","volume":"114","author":"L Holz","year":"2015","unstructured":"Holz L, Rehermann B . T cell responses in hepatitis C virus infection: historical overview and goals for future research. Antiviral Res 2015; 114: 96\u2013105.","journal-title":"Antiviral Res"},{"key":"BFcmi20164_CR183","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s10620-014-3473-z","volume":"60","author":"AJ Montano-Loza","year":"2015","unstructured":"Montano-Loza AJ, Czaja AJ . Cell mediators of autoimmune hepatitis and their therapeutic implications. Dig Dis Sci 2015; 60: 1528\u20131542.","journal-title":"Dig Dis Sci"},{"key":"BFcmi20164_CR184","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/hepr.12439","volume":"45","author":"M Isogawa","year":"2015","unstructured":"Isogawa M, Tanaka Y . Immunobiology of hepatitis B virus infection. Hepatol Res 2015; 45: 179\u2013189.","journal-title":"Hepatol Res"},{"key":"BFcmi20164_CR185","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","volume":"62","author":"MP Manns","year":"2015","unstructured":"Manns MP, Lohse AW, Vergani D . Autoimmune hepatitis\u2014Update 2015. J Hepatol 2015; 62: S100\u2013S111.","journal-title":"J Hepatol"},{"key":"BFcmi20164_CR186","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","volume":"31","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Korn T, Kuchroo VK, Anderson AC . Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 2008; 31: 252\u2013256.","journal-title":"J Autoimmun"},{"key":"BFcmi20164_CR187","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123\u20131132.","journal-title":"Nat Immunol"},{"key":"BFcmi20164_CR188","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.150.2.353","volume":"150","author":"G Del Prete","year":"1993","unstructured":"Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S . Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150: 353\u2013360.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR189","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M, Kuchroo VK . IL-17 and Th17 cells. Annu Rev Immunol 2009; 27: 485\u2013517.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi20164_CR190","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235\u2013238.","journal-title":"Nature"},{"key":"BFcmi20164_CR191","doi-asserted-by":"publisher","first-page":"195","DOI":"10.14348\/molcells.2015.2331","volume":"38","author":"WK Suh","year":"2015","unstructured":"Suh WK . Life of T follicular helper cells. Mol Cells 2015; 38: 195\u2013201.","journal-title":"Mol Cells"},{"key":"BFcmi20164_CR192","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/hep.27552","volume":"61","author":"GJ Webb","year":"2015","unstructured":"Webb GJ, Hirschfield GM . Follicles, germinal centers, and immune mechanisms in primary biliary cirrhosis. Hepatology 2015; 61: 424\u2013427.","journal-title":"Hepatology"},{"key":"BFcmi20164_CR193","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","volume":"183","author":"JM Fletcher","year":"2009","unstructured":"Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C et al. CD39+Foxp3+ regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009; 183: 7602\u20137610.","journal-title":"J Immunol"},{"issue":"2","key":"BFcmi20164_CR194","doi-asserted-by":"publisher","first-page":"996","DOI":"10.4049\/jimmunol.166.2.996","volume":"166","author":"S. Sebastiani","year":"2001","unstructured":"Sebastiani S, Allavena P, Albanesi C, Nasorri F, Bianchi G, Traidl C et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. In J Immunol 2001, 996\u20131002.","journal-title":"The Journal of Immunology"},{"key":"BFcmi20164_CR195","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","volume":"62","author":"HW Mittrucker","year":"2014","unstructured":"Mittrucker HW, Visekruna A, Huber M . Heterogeneity in the differentiation and function of CD8(+) T cells. Arch Immunol Ther Exp (Warsz) 2014; 62: 449\u2013458.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"BFcmi20164_CR196","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1182\/blood-2009-02-203935","volume":"114","author":"CS Hinrichs","year":"2009","unstructured":"Hinrichs CS, Kaiser A, Paulos CM, Cassard L, Sanchez-Perez L, Heemskerk B et al. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 2009; 114: 596\u2013599.","journal-title":"Blood"},{"key":"BFcmi20164_CR197","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12026-014-8529-9","volume":"59","author":"S Sinha","year":"2014","unstructured":"Sinha S, Itani FR, Karandikar NJ . Immune regulation of multiple sclerosis by CD8+ T cells. Immunol Res 2014; 59: 254\u2013265.","journal-title":"Immunol Res"},{"key":"BFcmi20164_CR198","doi-asserted-by":"publisher","first-page":"e94192","DOI":"10.1371\/journal.pone.0094192","volume":"9","author":"MC Boer","year":"2014","unstructured":"Boer MC, van Meijgaarden KE, Joosten SA, Ottenhoff TH . CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One 2014; 9: e94192.","journal-title":"PLoS One"},{"key":"BFcmi20164_CR199","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.4049\/jimmunol.0901772","volume":"183","author":"Y Wu","year":"2009","unstructured":"Wu Y, Wu W, Wong WM, Ward E, Thrasher AJ, Goldblatt D et al. Human gamma delta T cells: a lymphoid lineage cell capable of professional phagocytosis. J Immunol 2009; 183: 5622\u20135629.","journal-title":"J Immunol"},{"key":"BFcmi20164_CR200","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2004.05.003","volume":"113","author":"T Kenna","year":"2004","unstructured":"Kenna T, Golden-Mason L, Norris S, Hegarty JE, O'Farrelly C, Doherty DG . Distinct subpopulations of gamma delta T cells are present in normal and tumor-bearing human liver. Clin Immunol 2004; 113: 56\u201363.","journal-title":"Clin Immunol"},{"key":"BFcmi20164_CR201","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/liv.12011","volume":"33","author":"A Hoh","year":"2013","unstructured":"Hoh A, Dewerth A, Vogt F, Wenz J, Baeuerle PA, Warmann SW et al. The activity of gammadelta T cells against paediatric liver tumour cells and spheroids in cell culture. Liver Int 2013; 33: 127\u2013136.","journal-title":"Liver Int"},{"key":"BFcmi20164_CR202","doi-asserted-by":"publisher","first-page":"9564","DOI":"10.1128\/JVI.00927-08","volume":"82","author":"MN Ajuebor","year":"2008","unstructured":"Ajuebor MN, Jin Y, Gremillion GL, Strieter RM, Chen Q, Adegboyega PA . GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk. J Virol 2008; 82: 9564\u20139576.","journal-title":"J Virol"},{"key":"BFcmi20164_CR203","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.molimm.2012.05.017","volume":"52","author":"Y Lu","year":"2012","unstructured":"Lu Y, Wang X, Yan W, Wang H, Wang M, Wu D et al. Liver TCRgammadelta(+) CD3(+) CD4(-) CD8(-) T cells contribute to murine hepatitis virus strain 3-induced hepatic injury through a TNF-alpha-dependent pathway. Mol Immunol 2012; 52: 229\u2013236.","journal-title":"Mol Immunol"},{"key":"BFcmi20164_CR204","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/eji.200838354","volume":"38","author":"KA Rhodes","year":"2008","unstructured":"Rhodes KA, Andrew EM, Newton DJ, Tramonti D, Carding SR . A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol 2008; 38: 2274\u20132283.","journal-title":"Eur J Immunol"},{"key":"BFcmi20164_CR205","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/hep.26697","volume":"59","author":"L Hammerich","year":"2014","unstructured":"Hammerich L, Bangen JM, Govaere O, Zimmermann HW, Gassler N, Huss S et al. Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 2014; 59: 630\u2013642.","journal-title":"Hepatology"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/cmi20164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cmi20164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/cmi20164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T08:39:50Z","timestamp":1692261590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi20164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,21]]},"references-count":205,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["BFcmi20164"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2016.4","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,21]]},"assertion":[{"value":"19 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}